Questions To Califf In Second Confirmation Hearing Similar To Predecessors
However, the few Senate questions about industry ties, tobacco and food issues may surprise some observers.
You may also be interested in...
Making Progress On Novel OTC Switch Rulemaking Has FDA Commissioner Nominee Califf’s Attention
Responding to Sen. Roger Marshall’s question on rulemaking to accelerate OTC switches by allowing NDA sponsors to use extra-label information to guide consumers through self-selection of a drug, Robert Califf said he’d support making progress on a proposal FDA began considering in 2012 in its NSURE initiative.
Calculating Califf’s Course To Confirmation
Robert Califf got 89 votes in the Senate last time – but that’s also the least a Democratic nominee has ever gotten.
Califf Confirmation Hearing Round Two: Industry Ties Once Again May Bark Loud, Bite Lightly
The cardiologist seeking another term as FDA commissioner has been working in the pharma industry since leaving the post, but Senators have tended not to question nominee's work history extensively during previous confirmation hearings.